Operator of a biotechnology company aimed at developing an anticancer compound targeting the Golgi apparatus. The company is currently operating in stealth mode.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Merger/Acquisition | 01-Dec-2020 | Completed | Stealth | |||
1. Early Stage VC | 01-Oct-2011 | Completed | Stealth |
Growth Rate
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialInvestor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Truffle Capital | PE/Buyout | Minority | 000 0000 | 000000 0 |